Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can mindfulness ease the emotional toll of pulmonary fibrosis?

NCT ID NCT07782060

Symptom relief Sponsor: Queen's University, Belfast Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

Pulmonary fibrosis is a chronic lung condition that causes breathlessness and often brings anxiety and depression, yet few psychological supports exist. This trial tests a 4-week online mindfulness program, called Compassionate Mindful Resilience, designed to improve emotional well-being. The study includes 21 adults with pulmonary fibrosis in the UK or Ireland and focuses on whether the program is practical and acceptable to participants. Researchers will also measure changes in anxiety, depression, and well-being to see if the approach shows promise.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Compassionate Mindful Resilience (CMR) programme, a 4-week online, nurse-led mindfulness-based intervention
What this could lead to
If this program proves feasible, it could point toward a new, evidence-based psychological support option for people living with pulmonary fibrosis, potentially easing anxiety and depression.
What could go wrong
This is a small feasibility study, not a large effectiveness trial, so results may not be conclusive. The program requires internet access and commitment, which may limit who can benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

21 people

The number who actually took part.

Started

Dec 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * have a confirmed diagnosis of PF * be aged 18 years or older * reside in the UK or Ireland * have the capacity to provide informed consent * demonstrate a commitment to attend all four CMR sessions (demonstrated through discussion with the mindfulness teacher during screening) * have access to an internet-enabled device. Exclusion Criteria: * No diagnosis of PF * under 18 years old * live outside of UK or Ireland * no capacity to provide informed consent * not willing to attend all four CMR sessions * no access to an internet-enabled device.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pulmonary fibrosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pulmonary fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pulmonary fibrosis

Contacts and locations

Locations

  • Queen's University Belfast

    Belfast, Please Select, BT7 1NN, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.